Denzlingen, Germany

Gunther Weinheimer


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gunther Weinheimer: Innovator in Pyrrolocarbazole Derivatives

Introduction

Gunther Weinheimer is a notable inventor based in Denzlingen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrrolocarbazole derivatives.

Latest Patents

Weinheimer holds a patent for pyrrolocarbazole derivatives, compositions containing them, and methods for their preparation. This invention focuses on new pyrrolocarbazole derivatives that are designed to inhibit protein kinases, such as protein kinase C. The applications of these derivatives are extensive, as they can be used in the prevention and treatment of various heart and blood vessel diseases, including thromboses, arteriosclerosis, and hypertension. Additionally, they have potential uses in addressing inflammatory processes, allergies, cancers, degenerative damages of the central nervous system, and certain viral diseases.

Career Highlights

Gunther Weinheimer is associated with Goedecke Aktiengesellschaft, where he has been able to apply his expertise in developing innovative medicinal compounds. His work has not only advanced scientific understanding but also holds promise for improving patient outcomes in various medical conditions.

Collaborations

Weinheimer has collaborated with notable colleagues, including Jurgen Kleinschroth and Johannes Hartenstein. These partnerships have likely contributed to the success and development of his innovative projects.

Conclusion

Gunther Weinheimer's contributions to the field of medicinal chemistry through his patent on pyrrolocarbazole derivatives highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…